Trials / Completed
CompletedNCT02503696
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 697 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 18 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to gather stool samples from subjects with inflammatory bowel disease (IBD) to be added to a test set of stool samples that will be utilized to help select molecular markers and determine the optimal sensitivity and specificity values for the Exact IBD-ACRN surveillance test for colorectal cancer (CRC).
Conditions
- Inflammatory Bowel Disease
- Colorectal Neoplasms
- Digestive System Diseases
- Colonic Diseases
- Colorectal Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stool Collection Kit | Stool Collection Kit. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-11-01
- Completion
- 2016-06-01
- First posted
- 2015-07-21
- Last updated
- 2016-08-10
Locations
29 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02503696. Inclusion in this directory is not an endorsement.